Artemis Investment Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-81,553
| Closed | -$8.11M | – | 220 |
|
|
2024
Q4 | $8.11M | Sell |
81,553
-2,265
| -3% | -$234K | 0.12% | 150 |
|
|
2024
Q3 | $9.52M | Sell |
83,818
-45,218
| -35% | -$5.37M | 0.15% | 140 |
|
|
2024
Q2 | $16M | Buy |
129,036
+18,179
| +16% | +$2.34M | 0.21% | 113 |
|
|
2024
Q1 | $14.6M | Sell |
110,857
-1,642
| -1% | -$202K | 0.18% | 125 |
|
|
2023
Q4 | $12.3M | Sell |
112,499
-159,867
| -59% | -$16.6M | 0.18% | 110 |
|
|
2023
Q3 | $28M | Sell |
272,366
-302,382
| -53% | -$32.6M | 0.39% | 76 |
|
|
2023
Q2 | $66.2M | Sell |
574,748
-778,012
| -58% | -$88.3M | 0.83% | 34 |
|
|
2023
Q1 | $144M | Sell |
1,352,760
-187,792
| -12% | -$20.3M | 1.76% | 10 |
|
|
2022
Q4 | $172M | Buy |
1,540,552
+992,772
| +181% | +$101M | 1.95% | 6 |
|
|
2022
Q3 | $47.2M | Sell |
547,780
-38,777
| -7% | -$3.46M | 0.54% | 62 |
|
|
2022
Q2 | $53.7M | Buy |
586,557
+446,598
| +319% | +$39.6M | 0.55% | 60 |
|
|
2022
Q1 | $11.5M | Sell |
139,959
-78,059
| -36% | -$6.15M | 0.09% | 176 |
|
|
2021
Q4 | $16.7M | Buy |
+218,018
| New | +$17.4M | 0.12% | 157 |
|
|
2021
Q2 | – | Sell |
-186,377
| Closed | -$13.7M | – | 305 |
|
|
2021
Q1 | $13.7M | Sell |
186,377
-336,170
| -64% | -$24.8M | 0.13% | 175 |
|
|
2020
Q4 | $40.8M | Sell |
522,547
-7,925
| -1% | -$606K | 0.43% | 67 |
|
|
2020
Q3 | $41.9M | Buy |
530,472
+59,876
| +13% | +$4.69M | 0.53% | 52 |
|
|
2020
Q2 | $34.8M | Sell |
470,596
-658,748
| -58% | -$49.6M | 0.47% | 68 |
|
|
2020
Q1 | $83.1K | Buy |
1,129,344
+554,510
| +96% | +$43.6M | 0.14% | 18 |
|
|
2019
Q4 | $49.8M | Buy |
574,834
+93,130
| +19% | +$7.65M | 0.63% | 54 |
|
|
2019
Q3 | $38.6M | Buy |
481,704
+40,456
| +9% | +$3.24M | 0.53% | 63 |
|
|
2019
Q2 | $35.2M | Buy |
441,248
+108,373
| +33% | +$8.3M | 0.42% | 75 |
|
|
2019
Q1 | $26.4M | Buy |
332,875
+215,394
| +183% | +$16.1M | 0.31% | 96 |
|
|
2018
Q4 | $8.57M | Buy |
117,481
+35,632
| +44% | +$2.52M | 0.11% | 183 |
|
|
2018
Q3 | $5.54M | Buy |
+81,849
| New | +$5.21M | 0.06% | 242 |
|
|
2016
Q4 | – | Sell |
-211,662
| Closed | -$12.6M | – | 240 |
|
|
2016
Q3 | $12.6M | Buy |
+211,662
| New | +$12.4M | 0.35% | 85 |
|
|
2016
Q2 | – | Sell |
-192,889
| Closed | -$9.74M | – | 256 |
|
|
2016
Q1 | $9.74M | Sell |
192,889
-151,426
| -44% | -$7.42M | 0.25% | 100 |
|
|
2015
Q4 | $17.4M | Buy |
344,315
+120,148
| +54% | +$6.06M | 0.43% | 46 |
|
|
2015
Q3 | $10.6M | Buy |
224,167
+131,217
| +141% | +$6.97M | 0.31% | 84 |
|
|
2015
Q2 | $5.05M | Sell |
92,950
-146,415
| -61% | -$8.21M | 0.16% | 119 |
|
|
2015
Q1 | $13.1M | Sell |
239,365
-181,011
| -43% | -$10.2M | 0.52% | 39 |
|
|
2014
Q4 | $22.8M | Buy |
420,376
+87,782
| +26% | +$4.89M | 0.89% | 28 |
|
|
2014
Q3 | $18.8M | Buy |
+332,594
| New | +$18.7M | 0.94% | 36 |
|
Other funds holding MRK
Artemis Investment Management's MRK Position: Q1 2025 in Review
Artemis Investment Management sold out of Merck (MRK) in Q1 2025, closing a stake of 81,553 shares — an estimated $8.11M sold.
Artemis Investment Management first reported a position in MRK in Q3 2014 and held it in 32 quarters. The position peaked at $172M in Q4 2022. 3,447 funds tracked by Wall St. Rank hold MRK as of Q1 2025.
- Artemis Investment Management reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
- Artemis Investment Management sold 81,553 Merck shares in Q1 2025, an estimated $8.11M.
- Artemis Investment Management first reported a position in Merck in Q3 2014 and held it in 32 quarters.
- Artemis Investment Management's Merck position peaked at $172M in Q4 2022.
- 3,447 funds tracked by Wall St. Rank held Merck as of Q1 2025.
Based on Artemis Investment Management's 13F filing for Q1 2025, filed 24 Apr 2025.